Schedule 13G ownership disclosure

Context Therapeutics, Inc.

Common Stock, par value $0.001 per share · CUSIP: 21077P108

Event date: 2024-12-31

Filing-level shares
14,705,882.00
Percent of class
16.4%
  • MPM BioImpact LLC

    Shares: 14,705,882.00 · Class: 16.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-001117
Form type
SCHEDULE 13G
Filer
Context Therapeutics Inc.
CIK
CIK 1842952
Filed
Jan 08, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub